Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer

NCT02478502 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment

Conditions

Testicular Cancer

Interventions

DRUG: cabazitaxel

Sponsor

University Hospital, Akershus

Collaborators

[object Object]